Modulating effects of hesperidin on key carbohydrate-metabolizing enzymes, lipid profile, and membrane-bound adenosine triphosphatases against 7,12-dimethylbenz(a)anthracene-induced breast carcinogenesis

Human and Experimental Toxicology

Volumn 33, Issue 5, 2014, Pages 504-516

  Nandakumar, N ^a   Rengarajan, T ^a   Balamurugan, A ^a   Balasubramanian, M P ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

ATPases; breast cancer; glucose 6 phosphatase; hesperidin; Hexokinase; phospholipids; ROS

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ADENOSINE TRIPHOSPHATASE; CHOLESTEROL; CHOLESTEROL ESTER; FATTY ACID; FRUCTOSE BISPHOSPHATASE; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE ISOMERASE; HESPERIDIN; HEXOKINASE; LIPID; PHOSPHOLIPID; TRIACYLGLYCEROL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BREAST; BREAST CANCER; BREAST CARCINOGENESIS; CARBOHYDRATE METABOLISM; CELL MEMBRANE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; FATTY ACID BLOOD LEVEL; FEMALE; GLUCONEOGENESIS; HISTOPATHOLOGY; LIPID ANALYSIS; LIPOGENESIS; LIVER; LIVER CELL; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RAT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ATPASES; BREAST CANCER; GLUCOSE-6-PHOSPHATASE; HESPERIDIN; HEXOKINASE; PHOSPHOLIPIDS; ROS;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADENOSINE TRIPHOSPHATASES; ANIMALS; CARBOHYDRATE METABOLISM; CARCINOGENS; CELL MEMBRANE; FEMALE; HESPERIDIN; LIPID METABOLISM; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84899033888     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327113485252     Document Type: Article

References (77)

1. Schairer C, Mink PJ, Carroll L, Devesa SS. Probabilities of death from breast cancer and other causes among female breast cancer patients. J Nat Cancer Inst. 2004 ; 96: 1311-1321
2. Chang TW, Wang SM, Guo YL, Tsai PC, et al. Glutathione S-transferase polymorphism associated with risk of breast cancer in southern Taiwan. The Breast. 2006 ; 15: 754-761
3. Ferlay P, Autier M, Boniol M, Heanue M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007 ; 18: 581-592
4. Batcioglu K, Karagozler AA, Gene M, Celik S. Comparison of the chemopreventive potentials of melatonin and vitamin E plus selenium on 7,12-dimethylbenz(a)anthracene-induced inhibition of mouse liver antioxidant enzymes. Eur J Canc Prev. 2002 ; 11: 57-61
5. Cooke MS, Evans MD, Dizdaroglu M, Lunee J. Oxidative DNA damage: mechanisms, mutation, and disease. Faseb J. 2003 ; 17: 1214-1915
6. Hadi SM, Asad SF, Sing S, Ahmad A. Putative mechanism for anticancer and apoptosis-inducing properties of plant derived polyphenolic compounds. IUBMB Life. 2000 ; 50: 167-171
7. Lee JC, Lee KY, Son YO, Choi KC, et al. Plant-originated glycoprotein, G-120, inhibits the growth of MCF-7 cells and induces their apoptosis. Food Chem Toxicol. 2005 ; 43: 961-968
8. Compos AR, Lima RC, Uchoa DE, Silveira ER, et al. Pro-erectile effects of an alkaloidal rich fraction from Aspidosperma ulei root bark in mice. J Ehnopharmacol. 2006 ; 104 ((1-2)). 240-244
9. Barbosa NBV, Nogueira CW, Guecheva TN, Bellinaso ML, et al. Diphenyl diselenide supplementation delays the development on N-nitroso-N-methylurea- induced mammary tumors. Arch Toxicol. 2008 ; 82: 655-663
10. Vijayavel K, Anbuselvam C, Balasubramanian MP. Free radical scavenging activity of the marine mangrove Rhizophora apiculata bark extract with reference to naphthalene induced mitochondrial dysfunction. Chem Biol Interact. 2006 ; 163: 170-175
11. Ratnam DV, Ankola DD, Bhardwaj V, Sahana DK, et al. Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J Con Rel. 2006 ; 113: 189-207
12. Fraga CG, Martino VS, Ferraro GE, Cousio JD, et al. Flavonoids as antioxidants evaluated by in vitro and in vivo liver chemiluminescence. Biochem Pharmacol. 1987 ; 36: 717-720
13. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects and safety. Annu Rev Nutr. 2002 ; 22: 19-34
14. Kampa M, Nifli AP, Notes G, Castanas E. Polyphenols and cancer cell growth. Rev Physiol Biochem Pharmacol. 2007 ; 159: 79-113
15. Garg A, Garg S, Zaneveld LJD, Single AK. Chemistry and pharmacology of the citrus flavonoids hesperidin. Phytother Res. 2001 ; 15: 655-669
16. Deng W, Fang WI, Wu J. Flavonoids functions as antioxidants: by scavenging reactive oxygen species or by chelating iron?. Radiat Phys Chem. 1997 ; 50: 271-276
17. Suarez J, Herrera MD, Marhuenda E.. In vitro scavenger and antioxidant properties of hesperidin and neohesperidin dihydrochalcone. Phytomedicine. 1998 ; 5: 469-473
18. Malterud KE, Rydland KM. Inhibitors of 15-lipoxygenase from orange peel. J Agri Food Chem. 2000 ; 48: 5576-5580
19. Pradeep K, Park SH, Ko KC. Hesperidin a flavanoglycone protects against γ-irradiation induced hepatocellular damage and oxidative stress in Sprague - Dawley rats. Eur J Pharmacol. 2008 ; 587: 273-280
20. Nandakumar N, Jayaprakash R, Rengarajan T, Ramesh V, et al. Hesperidin, a natural flavanoglycoside, normalizes lipid peroxidation and membrane bound enzymes in 7, 12-dimethylbenz (a) anthracene induced experimental breast cancer rats. Biomed Prev Nutr. 2011 ; 1 (4). 255-262
21. Nandakumar N, Rengarajan T, Haribabu L, Perumal S, et al. Effect of flavanone hesperidin on the apoptosis of human mammary carcinoma cell line MCF-7. Biomed Prev Nutr. 2011 ; 1 (3). 207-215
22. Nandakumar N, Haribabu L, Perumal S, Balasubramanian MP. Therapeutic effect of hesperidin with reference to biotransformation, lysosomal and mitochondrial TCA cycle enzymes against 7,12-Dimethylbenz(a)anthracene induced experimental mammary cellular carcinoma. Biomed Aging Pathol. 2011 ; 1 (3). 158-168
23. Nandakumar N, Balasubramanian MP. Hesperidin protects renal and hepatic tissues against free radical mediated oxidative stress during DMBA induced experimental breast cancer. Environ Pathol Toxicol Oncol. 2011 ; 30 (4). 1-17
24. Barros AC, Muranaka EN, Mori LJ, Pelizon CH, et al. Induction of experimental mammary carcinogenesis in rats with 7,12-dimethylbenz(a)anthracene. Rev Hosp Clin Fac Med Sao Paulo. 2004 ; 59 (5). 257-261
25. Brandstrub N, Kirk JE, Bruni C. The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J Gerentol. 1957 ; 12 (2). 166-171
26. Horrocks JE, Ward J, King J. A routine method for the determination of phosphoglucoisomerase activity in body fluid. J Clin Pathol. 1963 ; 16 (3). 248-251
27. King J Practical Clinical Enzymology. Van D, ed. London, UK: Nostrand Co. Ltd ; 1965c: 191-208.
28. King J Practical clinical enzymology. Van D, ed. London, UK: Nostrand Co. Ltd ; 1965b: 83-93.
29. Gancedo JM, Gancedo C. Fructose-1,6-di-phosphatase, phosphofructokinase and glucose-6-phosphatase dehydrogenase from fermenting and non-fermenting yeasts. Arch Mikrobiol. 1971 ; 76: 132-138
30. Floch J, Less M, Stanley GHS.. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1951 ; 226: 497-509
31. Parekh AC, Jung DH. Cholesterol determinant with ferric chloride uranyl acetate and sulphuric acid ferrous sulphate reagent. Anal Biochem. 1970 ; 42: 1423-1427
32. Horn WT, Menahan LA. A sensitive method for the determination of free fatty acids in plasma. J Lipid Res. 1981 ; 23: 377-381
33. Rouser G, Fleisher S, Yamanoto A. Two dimensional thin layer chromotographic separation of polar lipids and determination of phospholipids by phosphorous analysis of spots. Lipids. 1970 ; 5: 494-496
34. Rice EW. Standard method of clinical chemistry. New York, NY: Academic Press ; 1970: 213-222.
35. Van Handel E. Modification of the micro determination of triglycerides. Clin Chem. 1961 ; 1: 249-251
36. Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem. 1925 ; 66: 375-400
37. Dodge JT, Mitchell C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin free ghosts of human erythrocytes. Arch Biochem Biophys. 1963 ; 100: 199-130
38. Quist EE.. Regulation of erythrocyte membrane shape by calcium ion. Biochem Biophys Res Commun. 1980 ; 92: 631-637
39. Bonting SL Membranes and ion transport. Bittar EE, ed. London, UK: Wiley-Interscience ; 1970: 257-363.
40. Hjerten S, Pan H. Purification and characterization of two forms of a low-affinity Ca2+-ATPase from erythrocyte membranes. Biochem Biophys Acta. 1983 ; 728: 281-288
41. Ohnishi T, Suzuki T, Suzuki Y, Ozawa K. A comparative study of plasma membrane Mg2+ - ATPase activities in normal, regenerating and malignant cells. Biochem Biophys Acta. 1962 ; 684: 67-74
42. Ortega AD, Arago MS, Sanchez DG, Cenizo LS, et al. Glucose avidity of carcinomas. Cancer Lett. 2009 ; 276: 125-135
43. Perumal SS, Shanthi P, Sachdanandam P. Therapeutic effect of tamoxifen and energy-modulating vitamins on carbohydrate-metabolizing enzymes in breast cancer. Canc Chemother Pharmacol. 2005 ; 56: 105-114
44. Golshani-Herbroni SG, Bessman SP. Hexokinase binding to mitochondria: a basis for proliferative energy metabolism. J Bioenerg Biomembr. 1997 ; 29: 331-338
45. Tisdales MJ. Biology of cachexia. J Natl Cancer Inst. 1997 ; 89: 1763-1773
46. Baggetto LG. Deviant energetic metabolism of glycolytic cancer cells. Biochemie. 1992 ; 74: 959-974
47. Eigenbrodt E, Glossmann H. Glycolysis one of the keys to cancer?. Trends Pharmacol Sci. 1980 ; 1: 240-245
48. Bannasch P, Mayer D, Hacker HJ. Hepatocellular glycogenesis and hepatocarcinogenesis. Biochim Biophys Acta. 1980 ; 605: 217-245
49. Parry DM, Pedersen PL. Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumour, evidence for an outer mitochondrial membrane location. J Biol Chem. 1983 ; 258: 10904-10912
50. Arora KK, Pedersen PL.. Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP. J Biol Chem. 1988 ; 263: 17422-17428
51. Hennipman A, Smit J, Van Oirschot BA, Van Houwelingen JC, et al. Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue. Tumor Biol. 1978 ; 8 (5). 251-263
52. Ebrahim AS, Balakrishnan K, Sakthisekaran D. Perchloroethylene induced alterations in glucose metabolism and their prevention by 2-deoxy-D-glucose and vitamin E in mice. J Appl Toxicol. 1996 ; 16: 339-348
53. Mazurek S, Zwerschke W, Jansen-Duerr P, Eigenbrodt E. Effects of the human papilloma virus HPV-16 E7 onco-protein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic enzymes complex. Biochem J. 2001 ; 356: 247-256
54. Hennipman A, Van Oirschot BA, Smits J, Rijksen G, et al. Heterogeneity of glycolytic enzyme activity and isoenzyme composition of pyruvate kinase in breast cancer. Tumour Biol. 1988 ; 9: 178-189
55. Schamhart DHJ, Van De Poll K, Van Wick R.. Comparative studies of glucose metabolism in HTC, RLC, MH1C1 and Reuber H35 rat hepatoma cells. Canc Res. 1979 ; 39: 1051-1055
56. Welsch CW. Relationship between dietary fat and experimental mammary tumorigenesis: a review and critique. Canc Res. 1992 ; 52: 2040-2048
57. Cave WT, Jurkowski JJ. Dietary lipid effects on the growth membrane composition, and prolactin-binding capacity of rat mammary tumors. J Natl Canc Inst. 1984 ; 73: 185-191
58. Clandinin MT, Cheema S, Field CJ, Garg ML, et al. Dietary fat: exogenous determination of membrane structure and cell function. Faseb J. 1991 ; 5: 2761-2769
59. Sumida C, Graber R, Nunez E. Role of fatty acids in signal transduction: modulators and messengers. Prostag Leukotr Ess. 1993 ; 48: 117-122
60. Merrill AH, Schroeder JJ. Lipid modulation of cell function. Annu Rev Nutr. 1993 ; 13: 539-559
61. Gupta S, Tandon VR, Kapoor B, Gupta A, et al. Effects of tamoxifen therapy on plasma lipid profile in patients of breast cancer. J Assoc Physicians India. 2006 ; 54: 183-186
62. Dessi S, Batetta B, Anchisi C, Pani P, et al. Cholesterol metabolism during the growth of a rat ascites hepatoma. Br J Canc. 1992 ; 66: 787-793
63. Tang W, Eisenbrand G Chinese drugs of plant origin. Berlin, Germany: Springer-Verlag ; 1992: 13-17.
64. Endo Y, Kukuchi T, Nakamura M. Orinithine and histidine decarboxylase activities in mice sensitized to endotoxin, interleukin-1 or tumor necrosis factor by D-galactosamine. Br J Pharmacol. 1992 ; 107: 888-894
65. Damen J, Ramshorst JV, Hoeven RPV. Alterations in plasma lipoprotein and heparin releasable lipase activities in mice bearing the GRSL ascites tumor. Biochem Biophys Acta. 1984 ; 793: 287-296
66. Kumar K, Sachadanandam P, Arivazhagan R. Studies on the changes in plasma lipids and lipoproteins in patients with benign and malignant breast cancer. Biochem Int. 1991 ; 23: 581-589
67. Veena K, Shanthi P, Sachdanandam P. The biochemical alterations following administration of Kalpaamruthaa and Semecarpus anacardium in mammary carcinoma. Chem Biol Interact. 2006 ; 161: 69-78
68. Plaa GL, Hewitt WR. Toxicology of the liver. Plaa GL Hewitt R, ed. New York, NY: Raven Press ; 1982: 103-120.
69. Kaur G, Tirkey N, Chopra K. Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity. Toxicol. 2006 ; 226: 152-160
70. Stekhoren MA, Bonting SL.. Transport of ATPases: properties and functions. Physiol Rev. 1981 ; 61: 1-76
71. Selvendiran K, Sakthisekaran D. Chemopreventive effect of piperine on modulating lipid peroxidation and membrane bound enzymes in benzo(a)pyrene induced lung carcinogenesis. Biomed Pharmacother. 2004 ; 58: 264-277
72. Geetha A, Marar T, Shyamala Devi CS.. Effect of α-tocopherol on doxorubicin induced changes in rat liver and heart microsomes. Ind J Exp Biol. 1991 ; 29 (8). 782-785
73. Ohta Y, Kongo-Nishimura M, Hayashi T, Kishikawa T. Effect or Oren-gedoku-To (Huanglian-Jie-Du-Tang) extract on disruption of hepatic antioxidant defense system in rats treated with D-galactosamine. J Ethanopharmacol. 2002 ; 94: 323-329
74. Jain SK, Shohet SB. Calcium potentiates the peroxidation of erythrocyte membrane lipids. Biochem Biophys Acta. 1981 ; 642: 46-54
75. Jain MP, Sharma VK. Phytochemical investigation of roots of Adhatoda vasica. Planta Med. 1982 ; 46: 250-253
76. Hebbel RP, Shalev O, Foker W, Rank BH. Inhibition of erythrocyte Ca2+-ATPase by activated oxygen through thiol and lipid dependent mechanisms. Biochem Biophys Acta. 1986 ; 862: 8-16
77. Nicotera P, Orrenius S. Role of thiol in protection against biological reactive intermediate. Adv Exp Med Biol. 1986 ; 187: 41-51